Company Univo Pharmaceuticals Ltd

Equities

UNVO-M

IL0010935588

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Biotechnology & Medical Research

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 08:49:49 2024-05-12 EDT			5-day change	1st Jan Change
93,000 ^ILa	0.00%		0.00%	0.00%

D-Pharm Ltd. is an Israel-based drug-development company. The Company is focused on developing drugs for the treatment of central nervous system (CNS) conditions. Its area of interest is in developing medicine for degenerative and age-related disorders. The Companyâs product portfolio includes three clinical Phase II drug-candidates: THR-18 for thrombolysis, to restore blood flow to the brain, heart or lungs, which completed clinical Phase I and Phase II study in acute stroke patients receiving tPA; DP-VPA for the treatment of epilepsy, migraine and manic depression, which has completed a Phase II study in patients with complex partial epilepsy, and DP-b99, which contains calcium, zinc and copper ions and is used for the protection of cells under stress in acute pancreatitis. The Companyâs two technology platforms Membrane Activated Chelator and Regulated Activation of Prodrug use lipid moieties conjugated onto actives such as metal ion chelators or drugs for site specific activation.

Number of employees: 76

ILS in Million	2020	Weight	2021	Weight	Delta
Medical Cannabis 89.4 %	19	57.3 %	38	89.4 %	+95.57%
Cannabis Product Manufacturing Services 7.7 %	5	15.0 %	3	7.7 %	-35.48%
Marketing and Distribution Commissions 2.1 %	1	2.5 %	1	2.1 %	+5.04%
Laboratory Services 0.6 %	8	25.1 %	0	0.6 %	-96.79%
Other Income 0.1 %	-	-	0	0.1 %	-

ILS in Million	2020	Weight	2021	Weight	Delta
Israel 100.0 %	34	100.0 %	42	100.0 %	+25.38%

Managers	Title	Age	Since
Golan Bitton CEO	Chief Executive Officer	48	93-04-03
Jonathan Eilat IRC	Investor Relations Contact	-	-
Noam Frakash AUD	Comptroller/Controller/Auditor	41	21-12-31

Members of the board	Title	Age	Since
Chaim Hurvitz CHM	Chairman	63	19-07-14
Golan Bitton CEO	Chief Executive Officer	48	93-04-03

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,293	1,952 ( 59.28 %)	0	59.28 %

Name	Equities	%	Valuation
Excellence Nessuah Mutual Funds Management Ltd. 0.000000 %	0	0.000000 %	- ILa
Ramco Mutual Funds Management (1989) Ltd. 0.000000 %	0	0.000000 %	- ILa
IBI Mutual Funds Management (1978) Ltd. 0.000000 %	0	0.000000 %	- ILa

Univo Pharmaceuticals Ltd.

20 HaHarash Street

7878320, Ashkelon

address Univo Pharmaceuticals Ltd(UNVO-M)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
UNIVO PHARMACEUTICALS LTD	0.00%	763K
MODERNA, INC.	+26.37%	48.16B
IQVIA HOLDINGS INC.	-1.01%	41.73B
LONZA GROUP AG	+41.70%	41.03B
CELLTRION, INC.	-5.31%	28.77B
ICON PUBLIC LIMITED COMPANY	+9.34%	25.59B
ALNYLAM PHARMACEUTICALS, INC.	-21.69%	18.96B
BIO-TECHNE CORPORATION	+6.23%	12.92B
MEDPACE HOLDINGS, INC.	+26.99%	12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.38%	11.77B

Other Biotechnology & Medical Research